RU96101852A - METHOD FOR ELIMINATING IMMUNE DISORDERS IN BRONCHIAL ASTHMA - Google Patents

METHOD FOR ELIMINATING IMMUNE DISORDERS IN BRONCHIAL ASTHMA

Info

Publication number
RU96101852A
RU96101852A RU96101852/14A RU96101852A RU96101852A RU 96101852 A RU96101852 A RU 96101852A RU 96101852/14 A RU96101852/14 A RU 96101852/14A RU 96101852 A RU96101852 A RU 96101852A RU 96101852 A RU96101852 A RU 96101852A
Authority
RU
Russia
Prior art keywords
bronchial asthma
immune disorders
day
eliminating immune
eliminating
Prior art date
Application number
RU96101852/14A
Other languages
Russian (ru)
Other versions
RU2130307C1 (en
Inventor
А.М. Земсков
С.М. Дунаев
В.И. Золоедов
Original Assignee
А.М. Земсков
Filing date
Publication date
Application filed by А.М. Земсков filed Critical А.М. Земсков
Priority to RU96101852A priority Critical patent/RU2130307C1/en
Priority claimed from RU96101852A external-priority patent/RU2130307C1/en
Publication of RU96101852A publication Critical patent/RU96101852A/en
Application granted granted Critical
Publication of RU2130307C1 publication Critical patent/RU2130307C1/en

Links

Claims (1)

Способ устранения иммунных нарушений при бронхиальной астме, заключающийся в применении обычной базисной терапии, отличающийся тем, что больным бронхиальной астмой в период обострения назначается спазмолитическое средство но-шпа по 0,02 г два раза в день и официальный препарат аллохол по одной таблетке три раза в день после еды в течение двух недель, как в комбинации с традиционными схемами лечения, так и раздельно.A method for eliminating immune disorders in bronchial asthma, which consists in the use of conventional basic therapy, characterized in that patients with bronchial asthma are prescribed an antispasmodic no-shpa at an exacerbation rate of 0.02 g twice a day and an official drug allochol, one tablet three times a day a day after a meal for two weeks, both in combination with traditional treatment regimens, and separately.
RU96101852A 1996-01-31 1996-01-31 Method for removing immune disturbances in cases of bronchial asthma RU2130307C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96101852A RU2130307C1 (en) 1996-01-31 1996-01-31 Method for removing immune disturbances in cases of bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96101852A RU2130307C1 (en) 1996-01-31 1996-01-31 Method for removing immune disturbances in cases of bronchial asthma

Publications (2)

Publication Number Publication Date
RU96101852A true RU96101852A (en) 1998-03-27
RU2130307C1 RU2130307C1 (en) 1999-05-20

Family

ID=20176370

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96101852A RU2130307C1 (en) 1996-01-31 1996-01-31 Method for removing immune disturbances in cases of bronchial asthma

Country Status (1)

Country Link
RU (1) RU2130307C1 (en)

Similar Documents

Publication Publication Date Title
EE04852B1 (en) C-21 Modified Epothiolones, Methods of Making and Using Them, and Use of a Pharmaceutical Composition in the Treatment of Cancerous or Other Proliferative Diseases
DE69027057D1 (en) Retinal, its derivatives and their therapeutic use
BR9607350A (en) Oral pharmaceutical dosage forms and a tablet and processes for preparing them and for treating disorders associated with dyspepsia in mammals and humans and use of the dosage form
EP1352896A3 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
CA2253837A1 (en) Therapeutic uses of bpi protein products for human meningococcemia
ITRM920412A0 (en) HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE.
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
ZA200203156B (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrindependent microcirculation disorders.
AU9598198A (en) Method and apparatus for improving human physical performance, training for athletic activities, preventing injury, physical therapy or the like
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
ZA925892B (en) Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases.
EP0795332A3 (en) Medical use of gamma-interferon in interstitial lung diseases
ZA913497B (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
RU96101852A (en) METHOD FOR ELIMINATING IMMUNE DISORDERS IN BRONCHIAL ASTHMA
ITRM960396A0 (en) USE OF ALCANOIL L-CARNITINE IN THE THERAPEUTIC TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL DISEASES.
CA2268213A1 (en) Thermogenesis stimulating drugs
Mareth Hair loss associated with fluoxetine use in two family members.
WO2004045497A3 (en) Cd26-based therapies for cancers and immune disease
DE60037402D1 (en) TREATMENT OF AUTOIMMUNE DISEASES WITH AN EXTRACT OF AMERICAN GINSENG
IT1214686B (en) BENZAMIDS, THEIR PREPARATION PROCEDURES AND THEIR APPLICATION IN THE THERAPEUTIC FIELD
EP0240366A3 (en) Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
RU94034142A (en) METHOD FOR NON-MEDICINAL TREATMENT OF PATIENTS WITH PSYCHOLOGICAL-VEGETATIVE DISORDERS
EP0622363A3 (en) 2-amino-5-cyano-4-quinolyldihydropyridine esters, process for their preparation and their use in medicine for the treatment of heart-circulatory illnesses.